Safety, immunization coverage and determinants of a new kind of Hepatitis B vaccine firstly applied in Ningbo, China

References

• Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet 2014;9938:2053-63; http://dx.doi.org/10.1016/S0140-6736(14)60220-8
   Web of Science ®Google Scholar
• Ganem D, Prince AM. Hepatitis B virus infection–natural history and clinical consequences. N Engl J Med 2004; 350:1118-29; PMID:15014185; http://dx.doi.org/10.1056/NEJMra031087
   PubMed Web of Science ®Google Scholar
• Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002; 2:395-403; PMID:12127351; http://dx.doi.org/10.1016/S1473-3099(02)00315-8
   PubMed Web of Science ®Google Scholar
• Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Shau WY, Liang DC Chen DC. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-9; PMID:9197213; http://dx.doi.org/10.1056/NEJM199706263362602
   PubMed Web of Science ®Google Scholar
• Kao JH, Hsu HM, Shau WY, Chang MH, Chen DS. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr 2001; 139:349-52; PMID:11562612; http://dx.doi.org/10.1067/mpd.2001.116277
   PubMed Web of Science ®Google Scholar
• Hung HF, Chen TH. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence. Vaccine 2009;27:6770-6; PMID:19735755; http://dx.doi.org/10.1016/j.vaccine.2009.08.082
   PubMed Web of Science ®Google Scholar
• World Health Organization. Hepatitis B.; Updated 28 2014 July 28;Cited 2014 Oct 19. Available from: www.who.int/mediacentre/factsheets/fs204/en/.
   Google Scholar
• Ando T, Sugiyama K, Goto K, Miyake Y, Li R, Kawabe Y, Wada Y. Age at time of hepatitis Be antibody seroconversion in childhood chronic hepatitis B infection and mutant viral strain detection rates. J Pediatr Gastroenterol Nutr 1999;29:583-7; PMID:10554127; http://dx.doi.org/10.1097/00005176-199911000-00020
   PubMed Web of Science ®Google Scholar
• Shimakawa Y, Yan HJ, Tsuchiya N, Bottomley C, Hall AJ. Association of early age at establishment of chronic hepatitis B infection with persistent viral replication, liver cirrhosis and hepatocellular carcinoma: a systematic review. PloS one 2013; 8:e69430; PMID:23894479; http://dx.doi.org/10.1371/journal.pone.0069430
   PubMed Web of Science ®Google Scholar
• Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995; 20:992-1000; PMID:7795104; http://dx.doi.org/10.1093/clinids/20.4.992
   PubMed Web of Science ®Google Scholar
• Hsieh CC, Tzonou A, Zavitsanos X, Kaklamani E, Lan SJ, Trichopoulos D. Age at first establishment of chronic hepatitis B virus infection and hepatocellular carcinoma risk. A birth order study. Am J Epidemiol 1992; 136:1115-21; PMID:1334366
   PubMed Web of Science ®Google Scholar
• Yao JL. Perinatal transmission of hepatitis B virus infection and vaccination in China. Gut 38 Suppl 1996;2:S37-8; http://dx.doi.org/10.1136/gut.38.Suppl_2.S37
   Google Scholar
• Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975;292:771-4; PMID:1113797; http://dx.doi.org/10.1056/NEJM197504102921503
   PubMed Web of Science ®Google Scholar
• Cui Y, Jia J. Update on epidemiology of hepatitis B and C in China. J Gastroenterol Hepatol 2013;1:28 Suppl 7-10; http://dx.doi.org/10.1111/jgh.12220
   Web of Science ®Google Scholar
• Zhang Y, Ma JC, Qi SX, Wang F, Zhao C, Bi SL. Effectiveness of a Chinese hamster ovary cell derived hepatitis B vaccine in Chinese rural communities. Vaccine 2011;29:3905-8; PMID:21457729; http://dx.doi.org/10.1016/j.vaccine.2011.03.030
   PubMed Web of Science ®Google Scholar
• Cui F, Liang X, Gong X, Chen Y, Wang F, Zheng H, Wu Z, Miao N, Hadler SC Hutin YJ, et al. Preventing hepatitis B though universal vaccination: reduction of inequalities through the GAVI China project. Vaccine 2013;231 Suppl 9:J29-35; http://dx.doi.org/10.1016/j.vaccine.2012.07.048
   Google Scholar
• Hadler SC, Fuqiang C, Averhoff F, Taylor T, Wang FZ, Li L, Liang XF Yang WZ. The impact of hepatitis B vaccine in China and in the China GAVI Project. Vaccine 2013;31 Suppl 9:J66-72; PMID:24331023; http://dx.doi.org/10.1016/j.vaccine.2013.03.043
   PubMedGoogle Scholar
• Kojouharova M, Teoharov P, Bahtchevanova T, Maeva I, Eginlian A. Safety and Immunogenicity of a Yeast-Derived Recombinant Hepatitis B Vaccine in Bulgarian Newborns. Infection 2001; 29:342-4; PMID:11787837; http://dx.doi.org/10.1007/s15010-001-1150-6
   PubMed Web of Science ®Google Scholar
• Velu V, Nandakumar S, Shanmugam S, Jadhav SS, Kulkarni PS. Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India. World J Gastroenterol 2007; 13:3084-9; PMID:17589924
   PubMed Web of Science ®Google Scholar
• Sun J, Han Y, Wang Y, Wang P, Jia XY, et al. Serum antibody response to different doses of hepatitis B vaccine made by recombinant DNA techniques in yeast and Hansenula polymorpha yeast. Chin Prev Med 2010;16:140-2
   Google Scholar
• Cui F, Luo H, Wang F, Zheng H, Gong X, Chen Y, Wu Z, Miao N, Kane M, Hennessey K, et al. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation. Vaccine 2013; 31 Suppl 9:J36-42; PMID:24331019; http://dx.doi.org/10.1016/j.vaccine.2012.11.061
   PubMedGoogle Scholar
• Esteghamati A, Keshtkar AA, Nadjafi L, Gouya MM, Salaramoliandel M, Roshandel G, Yaghini F. Hepatitis B vaccination coverage among Iranian children aged 15–26 months in 2006. East Mediterr Health J 2011;17:93-100
   PubMedGoogle Scholar
• Denis F, Cohen R, Martinot A, Stahl JP, Lery T, Le Danvic M, Gaudelus J. Evolution of hepatitis B vaccine coverage rates in France between 2008 and 2011. Med Mal Infect 2013; 43:272-8; PMID:23876204; http://dx.doi.org/10.1016/j.medmal.2013.06.016
   PubMed Web of Science ®Google Scholar
• Hu Y, Chen E, Li Q, Chen Y, Qi X. Immunization coverage and its determinants among children born in 2008–2009 by questionnaire survey in Zhejiang, China. AsiaPac J Public Health 2011; 27(2):NP1132-43
   Google Scholar
• Basaleem HO, Al-Sakkaf KA, Shamsuddin K. Immunization coverage and its determinants among children 12–23 months of age in Aden, Yemen. Saudi Med J 2010;31:1221-6; PMID:21063652
   PubMed Web of Science ®Google Scholar
• Smith PJ, Humiston SG, Parnell T, Vannice KS, Salmon DA. The association between intentional delay of vaccine administration and timely childhood vaccination coverage. Public Health Rep 2010;125:534-41; PMID:20597453
   PubMed Web of Science ®Google Scholar
• Kane MA, Hadler SC, Lee L, Shapiro CN, Cui F, Wang X, Kumar R. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization. Vaccine 31 Suppl 2013; 9:J15-20; http://dx.doi.org/10.1016/j.vaccine.2013.03.045
   Google Scholar
• Sapru A, Kulkarni PS, Bhave S, Bavdekar A, Naik SS. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study. J Trop Pediatr 2007;53:303-7; PMID:17478542; http://dx.doi.org/10.1093/tropej/fmm016
   PubMed Web of Science ®Google Scholar
• Cunha MP, Dorea JG, Marques RC, Leao RS. Vaccine adverse events reported during the first ten years (1998–2008) after introduction in the state of Rondonia, Brazil. BioMed Res Int 2013; 853083; PMID:23509790
   PubMedGoogle Scholar
• Carniel EF, Morcillo AM, Blotta MH, Da Silva MT, Mazzola TN, Antonio MA, Zanolli ML, Netto AA, Higashi HG, Raw I, et al. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth. Vaccine. 2008; 30:647-52; http://dx.doi.org/10.1016/j.vaccine.2007.11.048
   Web of Science ®Google Scholar
• Gupta I, Ratho RK. Immunogenicity and safety of two schedules of Hepatitis B vaccination during pregnancy. J Obstet Gynaecol Res 2003; 29:84-6; PMID:12755527; http://dx.doi.org/10.1046/j.1341-8076.2002.00076.x
   PubMed Web of Science ®Google Scholar
• Boxall EH, A Sira J, El-Shuhkri N, Kelly DA. Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. J Infect Dis 2004;190:1264-1269; PMID:15346336; http://dx.doi.org/10.1086/423818
   PubMed Web of Science ®Google Scholar
• Yang YJ, Liu CC, Chen TJ, Lee MF, Chen SH, Shih H, Chang MH. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan. Pediatric Infect Dis J 2003;22:584-8; PMID:12867831
   PubMed Web of Science ®Google Scholar
• Sijia Y, Hongju D. Survey on the coverage of hepatitis B immunoglobulin adminstration among infants born to hepatitis B surface antigen positive mother in Ningbo. Chin Prev Med 2013;14:413-6
   Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Lui J, Gong X, Chen Y, et al. Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009;27:6550-7; PMID:19729084; http://dx.doi.org/10.1016/j.vaccine.2009.08.048
   PubMed Web of Science ®Google Scholar
• Ying Zeng, Jie Li, Xue-fang Song, Xin-hong Pan, Ju-yi Zhang, et al. Safety evaiuation of 10µg/Dose hepatitis B vaccine made by recombinant deoxyribonucleic acid techniques in saccharomyces cerevisciae yeast among newborns. Chinese Journal of Vaccine and Immunization 2011;17:490-493, 515
   Google Scholar
• Chow SC, Shao J, Wang H. Sample Size Calculations in Clinical Research. Marcel Dekker. New York. 2003
   Google Scholar